We are live on ! Find out more
TPI

TIANYIN PHARMACEUTICAL
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

1 hedge funds and large institutions have $119K invested in TIANYIN PHARMACEUTICAL in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

0% more capital invested

Capital invested by funds: $119K → $119K ($0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$119K

TPI Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q1 2017, worth a combined $119K — unchanged from a quarter earlier.

Fund positioning in TPI was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held TIANYIN PHARMACEUTICAL (TPI) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $119K of TIANYIN PHARMACEUTICAL stock for Q1 2017, unchanged quarter-over-quarter.
  • 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q1 2017 and 0 closed out.

Based on aggregated 13F filings for Q1 2017.